Asthma Prevalence among Athletes in an Urban Adolescent Population.

OBJECTIVE: To identify individuals at risk of asthma by assessing the prevalence of asthma in an urban, athletic adolescent population using preparticipation physical evaluation (PPE) data. STUDY DESIGN: Using the Athlete Health Organization (AHO) PPE data from 2016 to 2019, asthma prevalence was collected by reported diagnosis in the history or physical. Chi-square tests and logistic regression were performed to characterize the relationship between asthma and social factors such as race, ethnicity, and income. Control variables such as age, body mass index, blood pressure, sex, and family history were also collected. RESULTS: Over 2016-2019, 1,400 athletes ranging from 9 to 19 years of age had completed PPEs (Table 1). A large percentage of student-athletes were found to have asthma (23.4%), of whom a majority 86.3% resided in low-income zip-codes. Additionally, 65.5% of athletes with asthma identified as Black, with race being associated with asthma prevalence (p < 0.05). Demographic factors like income, age, and gender were not significantly associated with asthma prevalence. CONCLUSIONS: Self-identified Black individuals reported higher prevalence of asthma when compared to the general population. Identifying factors like race and income that place adolescent athletes at risk of asthma is a key step to understanding the complex relationship between asthma and social determinants of health. This work advances the conversation for establishing best practices for serving vulnerable populations, as seen in this urban population of children with asthma.

Risk Factors for Stress Fractures in Female Runners: Results of a Survey.

BACKGROUND: Few studies compare women with and without stress fractures and most focus on younger, elite runners. HYPOTHESIS/PURPOSE: Compare risk factors between female runners with and without a stress fracture history. STUDY DESIGN: Case control. METHODS: An online survey targeting women age ≥18 years was distributed primarily via social media. Questions included demographics, running details, cross training, nutrition, injury history, medical/menstrual history, and medications. Women with stress fracture histories answered questions about location, number, and changes made. Data were compared between groups using t-tests, chi-square tests, or Fisher's exact tests. Multivariable logistic regression models simultaneously investigated associations of multiple factors using backward variable selection. RESULTS: Data from 1648 respondents were analyzed. Mean age was 40 years, and 25.4% reported stress fractures. Significant differences were found between groups for days/week running, mileage/week, running pace, years running, having a coach, cycling or swimming, calorie consumption for activity, other running injuries, medical history, medication/supplement intake, age at menarche, and going ≥6 months without a menstrual period. Odds of having a stress fracture were increased with osteopenia (OR 4.14), shin splints (OR 3.24), tendon injuries (OR 1.49), running >20 miles/week (OR 1.74-1.77) compared to 11-20 miles/week, having a coach (OR 1.86), and cycling (OR 1.15). Women running 11:00-11:59 minutes/mile or slower were less likely to have a stress fracture compared to those running 9:00-9:59 minutes/mile (OR 0.43-0.54). The odds of having a stress fracture were 1.43 times higher for going ≥ 6 months without a menstrual period. Use of calcium, probiotics, and vitamin D increased odds. Post fracture, common changes made were with cross training (49%), mileage (49%), and strength training (35%). CONCLUSIONS: Multiple intrinsic and extrinsic factors were identified for female runners who sustained one or more stress fracture during running. Prospective studies are warranted to infer a cause and effect relationship amongst these variables and stress fracture risk. LEVEL OF EVIDENCE: Level IV.

Physiological Factors of Female Runners With and Without Stress Fracture Histories: A Pilot Study.

BACKGROUND: Female runners are at increased risk of stress fractures (SFs) compared with men. Literature is lacking with regard to best practice for preventing and treating SFs in women. The purpose of the study was to compare physiological measures and running-related factors between women of various ages and running abilities with and without a history of running-related SFs. HYPOTHESIS: Women with and without SF histories will differ with regard to medical and menstrual history, bone health, body composition, nutrition, and running history. STUDY DESIGN: Prospective cohort study. LEVEL OF EVIDENCE: Level 2. METHODS: A total of 20 female runners with SF histories were matched based on age and running distance with 20 women without SF histories. Data included medical, menstrual, running, injury, and nutritional histories; blood histology related to nutritional, hormonal, and bone-related risk factors; and bone density, fat, and lean tissue using dual energy x-ray absorptiometry. Paired t tests were used to examine differences between women with and without SF histories, and Spearmen correlations were conducted to examine relationships between physiological factors. RESULTS: Women with SF histories had lower hip bone mineral density compared with women without SF histories (P < 0.05). SF history was moderately correlated with menstrual changes during increased training times (r = 0.580; P < 0.0001) but was not correlated with any other physiological factor. There was a moderate correlation within the SF group (r = 0.65; P = 0.004) for bone markers for resorption and formation both increasing, indicating increased bone turnover. CONCLUSION: Female runners with low hip bone mineral density, menstrual changes during peak training, and elevated bone turnover markers may be at increased risk of SF. CLINICAL RELEVANCE: Female runners need routine screening for risks associated with SF occurrence. As bone mineral density and bone turnover markers are not routinely assessed in this population, important risk factors may be missed.

Perceptions of risk for stress fractures: A qualitative study of female runners with and without stress fracture histories.

OBJECTIVES: To gain insight into perceived factors related to bone health and stress fracture (SF) prevention for female runners and to understand their experiences within the medical community. DESIGN: Cohort qualitative study. SETTING: University health system. PARTICIPANTS: Forty female runners, 20 who had SF histories and 20 age-and-running-distance matched women without SF. MAIN OUTCOME MEASURES: Women participated in audiotaped qualitative semi-structured interviews. For women with a SF history, questions sought their perspectives on factors that they felt contributed to SF, experiences with the medical community, and changes made post SF. For women without a SF history, questions sought perspectives on factors felt important to perceived running-related bone health. RESULTS: Six themes emerged; 1) Previous/Recurrent Musculoskeletal Injuries, 2) Activity Patterns and Training Regimens, 3) Nutrition, 4) Prevention and Intervention, 5) Pain, and 6) Mindset. Within these themes, between group differences are characterized by differences in knowledge and/or application of knowledge for health and wellness. Compared to women without SF, women with SF histories increased training load more quickly, had poorer nutrition, performed less cross-training, and kept running despite pain. CONCLUSIONS: More education is needed for female runners to decrease risks for SF.

Upper Extremity Deep Vein Thromboses: The Bowler and the Barista.

Effort thrombosis of the upper extremity refers to a deep venous thrombosis of the upper extremity resulting from repetitive activity of the upper limb. Most cases of effort thrombosis occur in young elite athletes with strenuous upper extremity activity. This article reports two cases who both developed upper extremity deep vein thromboses, the first being a 67-year-old bowler and the second a 25-year-old barista, and illustrates that effort thrombosis should be included in the differential diagnosis in any patient with symptoms concerning DVT associated with repetitive activity. A literature review explores the recommended therapies for upper extremity deep vein thromboses.

High Prevalence of Obesity and High Blood Pressure in Urban Student-Athletes.

OBJECTIVES: To assess the prevalence of obesity and hypertension-level blood pressures in an urban, athletic adolescent population using preparticipation physical evaluation (PPE) data. STUDY DESIGN: The Athlete Health Organization provides free preparticipation physical evaluations to Philadelphia student-athletes via an annual mass-screening event. From 2009 to 2012, Athlete Health Organization personnel performed PPEs on more than 2700 middle school and high school athletes. The PPE included biometric information, a history, and a physical examination. Medical volunteers measured blood pressures using a manual blood pressure cuff with an aneroid manometer. The data from each PPE were collected and analyzed for prevalence of obesity, overweight, and hypertension-level blood pressure readings. RESULTS: A large percentage of student-athletes were found to be overweight (20%) or obese (24.0%). Many of these athletes also had stage 1 or 2 level blood pressure readings (14.8%), a finding which strongly correlated with elevated body mass index (P < .00001). CONCLUSIONS: The cardiovascular health of this urban adolescent athletic population is a major concern because their rates of obesity and elevated blood pressure place them at increased risk of cardiovascular complications later in life despite their participation in school athletics.

A Unique Incidental Finding in Two Young Dancers: A Case Series.

Dancers frequently present to the sports medicine clinic with a variety of lower extremity complaints ranging from acute and traumatic injuries to more chronic, overuse injuries. This case series depicts a similar and unique incidental radiographic finding found in 2 young dancers seen at the same sports medicine clinic. While the findings are likely benign and unrelated to both patients' initial presentation, the finding of acroosteolysis can be found in more serious systemic and genetic processes as well an early finding in repetitive trauma.

Antibiotic precautions in athletes.

CONTEXT: Antibiotics are the mainstay of treatment for bacterial infections in patients of all ages. Athletes who maximally train are at risk for illness and various infections. Routinely used antibiotics have been linked to tendon injuries, cardiac arrhythmias, diarrhea, photosensitivity, cartilage issues, and decreased performance. EVIDENCE ACQUISITION: Relevant articles published from 1989 to 2012 obtained through searching MEDLINE and OVID. Also, the Food and Drug Administration website was utilized. STUDY DESIGN: Clinical review. LEVEL OF EVIDENCE: Level 3. RESULTS: The team physician should consider alternative medications in place of the "drug of choice" when adverse drug effects are a concern for an athlete's health or performance. If alternative medications cannot be selected, secondary preventative measures, including sunscreen or probiotics, may be needed. CONCLUSION: Physicians choose medications based on a variety of factors to help ensure infection resolution while limiting potential side effects. Extra precautions are indicated when treating athletes with certain antibiotics.

Nonprescription pain medication use in collegiate athletes: a comparison of samples.

BACKGROUND: Despite recent research, nonprescription pain medication use among collegiate athletes across all divisions of the National Collegiate Athletic Association (NCAA) is still not well understood. HYPOTHESIS: Non-Division I-A NCAA athletes have a different usage pattern of nonprescription pain medication than NCAA Division I-A football athletes. METHODS: A modified version of a nonprescription medication usage survey that had been used with Division I-A football athletes was distributed to Division II and Division III athletes during pre-participation exams. The statistics were analyzed by calculating the z-ratio for the significance of the difference between 2 independent proportions. RESULTS: A total of 198 athletes from 16 different sports were surveyed. It was found that 62% of athletes used nonprescription medications for sports-related pain, which was significantly lower than previous findings for Division I-A football athletes: 12% reported taking more than the recommended dose; 1.5% reported taking nonprescription pain medication for > 10 consecutive days; and 38% reported that they read the label the first time they took a new nonprescription pain medication. These results, when compared with findings on Division I-A football athletes, demonstrated that Division II and III athletes are less likely to take more than the recommended dose of nonprescription pain medications and are less likely to use the medications for > 10 consecutive days-characteristics that are used to define misuse. Similar results were found when comparing Division I-A football athletes with non-Division I-A football athletes. CONCLUSIONS: Athletes from NCAA Division II and Division III sports appear to use nonprescription pain medication for sports-related pain less often and have lower rates of misuse than do Division I-A football athletes. Division I-A football athletes may be more likely to misuse nonprescription pain medication than non-Division I-A athletes. Special attention should be paid to this population to help reduce adverse event risks.

Hip fracture in older patients: tips and tools to speed recovery.

Delirium and VTE are among the many complications that can derail rehabilitation efforts. These tips can help you keep treatment on track.

Male sexual dysfunction.

Male sexual dysfunction is a common entity in primary care practice. The 3 most common types are erectile dysfunction, premature ejaculation, and decreased libido. Clinicians must be comfortable and skilled in taking a complete sexual, social, and medical history and performing a physical examination in persons complaining of sexual dysfunction. Treatment of male sexual dysfunction may include medications and individual or couples psychotherapy. Treatment should be aimed at reducing emotional and physical morbidity in the patient and his partner.